Background {#Sec1}
==========

*Ashbya gossypii,* a filamentous fungus, is a riboflavin producer and has been utilized for industrial riboflavin production. Therefore, many studies on the metabolic mechanism of riboflavin production in *A. gossypii* have been carried out, and several overproducing mutants have been isolated \[[@CR1]\]. In addition, the genome of *A. gossypii* is very similar to that of *Saccharomyces cerevisiae*, which is a budding yeast, and 91% of 4476 annotated *A. gossypii* genes are syntenic to those of *S. cerevisiae* \[[@CR2]\]. This finding provides for many researchers to identify differences between the growth of filamentous fungi and budding yeasts \[[@CR3]\].

Isocitrate lyase (ICL), which catalyzes the cleavage reaction of isocitrate to succinate and glyoxylate, is an important enzyme for riboflavin production in *A. gossypii* \[[@CR4]\]. The mutant isolated using itaconate, which is an ICL inhibitor, produced a 25-fold higher level of riboflavin in soybean oil-containing medium than the wild type. The mutant isolated on oxalate-containing medium showed a 5-fold higher riboflavin yield than wild type in rapeseed oil medium \[[@CR5]\]. In addition, genetic engineering of this fungus has been utilized for riboflavin production \[[@CR6]\]. Overexpression of riboflavin biosynthetic genes in *A. gossypii* contributed to the enhancement of riboflavin production \[[@CR7]\]. Disruption of cytoplasmic serine hydroxymethyltransferase gene (*AgSHM2*) in *A. gossypii* also improved riboflavin production 10-fold compared to the wild type \[[@CR8]\]. Reinforcement of the purine biosynthetic pathway in *A. gossypii* also improved riboflavin production \[[@CR9], [@CR10]\]. These results show that glycine and the purine biosynthetic pathway are important factors for riboflavin production in *A. gossypii*. Along with genetic engineering, metabolic investigation using a ^13^C tracer has been carried out to improve riboflavin production in *A. gossypii* \[[@CR11], [@CR12]\].

Recently, the *A. gossypii* w122032 mutant (MT strain), which is an overproducer of riboflavin, was isolated by the disparity mutagenesis method \[[@CR13]\]. This disparity mutagenesis was first demonstrated by Furusawa et al., and disparity theory has been developed by computer simulation \[[@CR14], [@CR15]\]. Expression of error-prone DNA polymerase δ in hosts generates increased diversity of hosts that have mutated genomes and leads to the isolation of mutant strains with desired properties. In the MT strain, mutation sites in metabolic pathways were suggested by DNA microarray analysis, proteome analysis and metabolic flux analysis \[[@CR13], [@CR16]\]. However, definite mutation sites have not been identified to date.

In this study, using a next-generation DNA sequencer, genome analysis of the MT strain was carried out, and mutation sites in the genome of this mutant compared to that of wild type were determined to clarify the mechanism of the riboflavin over-production in MT strain considering the previous analyses of MT strain \[[@CR13], [@CR16]\]. In addition, we discussed the roles of genes mutated in the MT strain.

Results and discussion {#Sec2}
======================

Genome analysis of each strain and identification of mutations in the genome sequence of MT {#Sec3}
-------------------------------------------------------------------------------------------

We previously reported that the riboflavin over-producing mutant (MT strain) was isolated by disparity mutagenesis in the presence of H~2~O~2~, itaconate and oxalate and phenotypes of this MT strain were characterized by transcriptomic, proteomic and metabolic flux analyses \[[@CR13], [@CR16]\]. In this study, to reveal the genotype of MT strain, genome resequencing and single-nucleotide polymorphisms (SNP) analysis were carried out. Whole-genome shotgun sequencing for WT and MT generated 1,083,909 and 1,519,777 high-quality read pairs totaling approximately 593 and 836 Mb, respectively. The high-quality reads of WT and MT were aligned to the reference genome of *A. gossypii* ATCC10895, resulting in sequence coverages of 41.9--43.4 and 46.7--53.6, respectively, for chromosome I--VII. Among the variants identified by the Genome Analysis Toolkit (GATK) based on the aligned reads for WT and MT, mutations in open reading frames (ORFs), missense mutations, frameshift mutations and nonsense mutations were analyzed. In WT, which is same as the original strain *A. gossypii* ATCC10895, amino acid sequences encoded by all ORFs were the same as those of strain ATCC10895, except for the *SEN2* gene (AGOS_AGR073C), which encodes a subunit of the tRNA splicing endonuclease in *S. cerevisiae* (Supplementary material Table [S1](#MOESM1){ref-type="media"}). This result indicates that this WT, which has been maintained in our laboratory, could have gained this heterozygous mutation. However, this WT was used in this study because this gene may not be involved in riboflavin production, given the function of the gene product. Additionally, some silent mutations were also detected (data not shown).

From the single-nucleotide variant (SNV) analysis between the genome sequences of WT and MT, we detected 33 homozygous and 1377 heterozygous mutations in the coding sequences of the genome of MT strain (Supplementary materials Tables [S1](#MOESM1){ref-type="media"} and [S2](#MOESM1){ref-type="media"}), which cause missense, nonsense and frameshift mutations, in addition to silent mutations. These heterozygous mutations suggest that nuclei of the MT strain are polyploid. In the 1377 heterozygous mutations, the proportion of mutations in each gene was different. The highest proportion was 75% (chromosome VI:799,900 in *AgOCT1*, AGOS_AFR198W), and the lowest proportion was 21% (chromosome VII:198,537 and 198541 in *AgATP1*, AGOS_AGL272C) (Fig. [1](#Fig1){ref-type="fig"}). Most heterozygous mutants were found to have ratios of 40--60%. These results suggest that the MT strain may contain multiple nuclei containing different mutations. To prove its ploidy, we tried to isolate haploid spores from the MT strain, but this strain did not produce spores under the conditions tested. This result indicates that the MT strain lost the ability to sporulate even though it was previously reported that the riboflavin production in *A. gossypii* is related with its spore production \[[@CR17]\]. *A. gossypii* is a naturally multinucleate fungus, but this fungus may be haploid, and the spores of this fungus produced by asexual sporulation are also haploid \[[@CR2], [@CR18]\]. However, Anderson et al. reported that ploidy variation was observed in *A. gossypii* with minor aneuploidy \[[@CR19]\]. In this study, the proportion of heterozygous mutations in each gene ranged from 75 to 21%, and most heterozygous mutations were found at 40--60%. This result may be caused by the polyploidy or multinucleate cells of this organism. Anderson et al. \[[@CR19]\] also discussed the low germination frequency of spores produced from variable polypoid nuclei. Two possibilities were suggested: a reduction in ploidy to uninucleate haploid spores and the formation of spores with variable ploidy. In this study, the MT strain never produced haploid spores. Fig. 1Proportion of mutated reads in each gene among 1377 heterozygous mutations in the coding sequences of the MT genome. The highest proportion was 75% (OCT1, AGOS_AFR198W), and the lowest proportion was 21% (AGOS_AGL272C). Most heterozygous mutations were detected at 40--60%

Which corresponds, interestingly, we found a region representing \~ 2-fold sequence coverage compared to other regions in chromosome VII of the MT strain, which correspond to the rRNA gene repeats (Chr VII:441,317-762,344) (Fig. [2](#Fig2){ref-type="fig"}). In yeasts, the number of rRNA gene repeats is normally maintained for genome stability and determination of life span \[[@CR20], [@CR21]\]. Moreover, the rRNA gene controls chromosome homeostasis \[[@CR22]\]. When the number of rRNA gene repeats increases, rRNA gene instability and aging phenotypes are observed. Silva et al. showed that the riboflavin-overproducing *Ashbya* mutants are vulnerable to photoinduced oxidative DNA damage and accumulate reactive oxygen species (ROS) \[[@CR23]\]. The ROS is largely involved in the aging of cells, suggesting that the riboflavin production in *A. gossypii* may be associated with the aging of cells. Fig. 2Sequence coverage line graph of chromosomes in MT strain and WT strain. Compared to the WT strain, a large number of rRNA gene repeat sequences in chromosome VII were detected in the MT strain

It is reasonable that homozygous mutations have more crucial effects on riboflavin production in the MT strain compared to heterozygous mutations. We selected candidate mutations among 33 homozygous mutations in the coding sequence of the genome of MT strain, as shown in Table [1](#Tab1){ref-type="table"}. Among the 33 homozygous mutations, the *SEN2* gene (AGOS_AGR073C) has one homozygous mutation in the MT strain, in contrast to the WT strain used in this study, which has one heterozygous mutation at the same nucleotide. Four homozygous mutations in the amino acid metabolism of *A. gossypii* were detected. Table 1Homozygous mutations of genes in MT strainChromosomePositionWT seq.MT seq.QualityMutationGeneProductDNA changesProtein changesNumberWT seq.MT seq.II496,139CT1495.42missenseAGOS_ABR055CTranscriptional activator (AgSOK2 or AgPHD1)c.1180G \> AG394R038III726,948CGC1167.38frameshiftAGOS_ACR215CCytosolic serine hydroxymethyltransferase (AgSHM2)c.1332delCp.Q445fs030IV1,433,004TA1442.42missenseAGOS_ADR404COleate-activated transcription factor (AgOAF1 or AgPIP2)c.2317A \> Tp.T773S038IV1,433,040TG1455.42missenseAGOS_ADR404COleate-activated transcription factor (AgOAF1 or AgPIP2)c.2281A \> Cp.T761P039IV199,365GA1523.42missenseAGOS_ADL287CChorismate synthase (AgARO2)^a^c.206C \> Tp.T69M039V70,024CA1836.42missenseAGOS_AEL305CLarge subunit of acetohydroxyacid synthase (AgILV2)^a^c.1365G \> Tp.Q455H046VII791,717CA1505.42missenseAGOS_AGL123WCytidine deaminase (AgCDD1)c.314C \> Ap.P105Q041VII962,069GA1560.42nonsenseAGOS_AGL036CHeat shock protein 104 (AgHSP104)c.1066C \> Tp.Q356\*042VI1,753,850GA1884.42missenseAGOS_AGR382WL-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (AgLYS5)c.365G \> Ap.R122H049These homozygous mutations are a subset among all 32 homozygous mutations which are shown in Table [S1](#MOESM1){ref-type="media"}^a^Flavoproteins\*Translation stops here

First, a frameshift mutation in the *AgSHM2* gene (AGOS_ACR215C) was detected in the genome of the MT strain. This gene encodes serine hydroxymethyltransferase 2 (SHMT), and it was previously reported that disruption of this gene enhanced the productivity of riboflavin in *A. gossypii*, although the growth of the organism was compromised \[[@CR7]\]. The frameshift mutation causes the deletion of 25 amino acid residues at the C-terminus of AgSHM2 and the addition of 6 extra amino acid residues in the deletion mutant. This C-terminal region may not be directly involved in catalytic activity \[[@CR24]\]. However, the L474F mutation in this region of human and rabbit SHMT causes a decrease in the binding of this protein to co-factors \[[@CR25]\]. Therefore, this frameshift mutation in the MT strain may lead to a decrease in the SHMT activity of AgSHM2. In addition to the homozygous frameshift mutation, one heterozygous mutation (593G → A), which causes a missense mutation, R198Q, was also detected in the *AgSHM2* gene.

Second, a missense mutation (206C → T) in the *AgARO2* gene (AGOS_ADL287C), which produces the T69M mutant, was detected. In *S. cerevisiae*, this gene encodes chorismate synthase, which produces chorismate, a building block of aromatic compounds. Because T69 in the chorismate synthase of *S. cerevisiae* is distant from the catalytic site, this residue may not be directly involved in catalytic activity \[[@CR26]\]. In addition, this enzyme also exhibits flavin reductase activity for the synthesis of reduced flavin mononucleotide (FMN), which is required for chorismate synthase activity.

Third, a missense mutation (1365G → T) in the *AgILV2* gene (AGOS_AEL305C), which produces the Q455H mutant, was detected. In *S. cerevisiae*, this gene encodes the large subunit of acetohydroxyacid synthase (AHAS), which solely catalyzes the synthesis of 2-acetolactate and 2-aceto-2-hydroxybutyrate. This reaction is the first step of branched-chain amino acid biosynthesis. This mutation may not have considerable effects on enzymatic activity because Q455 is not in the co-factor-binding sites \[[@CR27]\]. This enzyme requires flavin adenine dinucleotide (FAD) as a co-factor, even though this reaction does not require oxidation and reduction. A small subunit of AHAS encoded by the *ScILV6* gene regulates the AHAS activity of ScILV2 in yeast \[[@CR28]\]. *A. gossypii* also has *AgILV2* and *AgILV6* genes. In *AgILV6* genes, three heterozygous missense mutations (140G → A, S47N; 155G → A, S52N; 673G → T, G225C) were detected.

Fourth, a missense mutation (365G → A) in the *AgLYS5* gene (AGOS_AGR382W), which produces the R122H mutant, was detected. In *S. cerevisiae*, ScLYS5 (4′-phosphopantetheinyl transferase, PPTase) converts the apo-form of ScLYS2 (α-aminoadipate reductase) to the active holo-form by the transfer of phosphopantetheine and is present in the lysine biosynthetic pathway \[[@CR29]\]. In addition to modification, PPTase is involved in fungal growth, the biosynthesis of secondary metabolites and asexual and sexual development \[[@CR30], [@CR31]\].

In pyrimidine metabolism in *A. gossypii*, one homozygous mutation was detected in the *AgCDD1* gene (AGOS_AGL123W), which encodes cytosine deaminase in *S. cerevisiae*. This enzyme catalyzes the conversion of cytidine to uridine in the pyrimidine salvage pathway in *S. cerevisiae* \[[@CR32]\]. In *A. gossypii*, in the pyrimidine salvage pathway, uracil phosphoribosyltransfrase, encoded by the *AgFUR1* gene, controls the amount of phosphoribosyl pyrophosphate (PRPP), which is one of the precursors of riboflavin in this organism \[[@CR33]\].

Regarding the riboflavin production in *A. gossypii*, one missense homozygous mutation (1180G → A) was detected in *AgSOK2* gene (AGOS_ABR055C) of MT strain. AgSOK2 is one of fungal-specific group of transcription factors and involved in the sporulation and riboflavin production in *A. gossypii* \[[@CR34]\]. Deletion of *AgSOK2* gene led to the strong reduction of the riboflavin production and the deficiency of the sporulation by the downregulation of *AgIME2* and *AgNDT80* gene. In MT strain, the riboflavin overproduction and the sporulation deficiency were observed even though *AgSOK2* gene had one homozygous mutation. Therefore, it is possible that the riboflavin production and the sporulation in *A. gossypii* may be regulated differently by AgSOK2 or the homozygous mutation in *AgSOK2* gene may cause the sporulation deficiency but may not cause the reduction of riboflavin production.

Two homozygous mutation (2317A → T and 2281A → C) in *AgOAF1* gene (AGOS_ADR404C) were also found in the genome of MT strain. In the conventional medium previously reported (initial rapeseed oil concentration 100 g/L) \[[@CR13]\], WT and MT strains consumed 78.6 and 62.7 g/L of rapeseed oil for 144 and 168 h cultivation in a 3 L jar-fermentor, respectively (unpublished data). Riboflavin production in WT and MT strains during the cultivation was 1.52 and 6.49 g/L, respectively. This result corresponded to the data in this study showing two homozygous mutations in *AgOAF1* gene (AGOS_ADR404C) encoding a subunit of an oleate-activated transcription factor which binds to the oleate response element in promoters of oleate-responsive genes. *A. gossypii* has more two genes encoding homologs of ScOAF1 gene (AGOS_ADR403C and AGOS_ADR405C). AGOS_ADR403C and AGOS_ADR405C also had one and two heterozygous mutations, respectively (Supplementary material Table [S2](#MOESM1){ref-type="media"}).

In the MT strain, 1377 heterozygous mutations in the coding sequences were also detected (Supplementary material Table [S2](#MOESM1){ref-type="media"}). Heterozygous mutations usually lead to less critical effects than homozygous mutations \[[@CR35], [@CR36]\]. However, heterozygous mutations sometimes have negative effects on protein functions as well as haploinsufficiency \[[@CR37], [@CR38]\]. In addition, some mutated proteins that form multimers exhibit dominant-negative effects on functions \[[@CR39], [@CR40]\]. Therefore, it is possible that heterozygous mutations also have some effect on riboflavin production in the MT strain. Among the 1377 heterozygous mutations in the coding sequences, unusual heterozygous mutations were detected (Table [2](#Tab2){ref-type="table"}). Most genes in the TCA cycle have heterozygous mutations. In particular, three genes, namely, *AgSDH1* (AGOS_ACR052W), *AgSDH2* (AGOS_ACL065C), and *AgSDH3* (AGOS_AFR207C), encoding subunits of succinate dehydrogenase in *S. cerevisiae*, have heterozygous mutations. In addition, several genes encoding flavoproteins in the mitochondria also have heterozygous mutations. AgSDH1 is also a flavoprotein. Flavoproteins in mitochondria of yeasts function in redox processes via the transfer of electrons \[[@CR41]\]. In addition, the flavin in flavoproteins participates in the reduction of heme iron or iron-sulfur clusters. In this study, we detected several homozygous mutations (*AgARO2*, *AgILV2*) and heterozygous mutations {*AgSDH1*, *AgPDX1* (AGOS_AGR323C), *AgNDI1* (AGOS_AFR447C), *AgDLD1* (AGOS_AER321W), *AgCBR1* (AGOS_ADL087W), *AgGLR1* (AGOS_AGR196W), *AgMTO1* (AGOS_AGR196W), *AgMET5* (AGOS_ABL077W), *AgPUT1* (AGOS_AGL165W), *AgFAS1* (AGOS_AER085C), *AgHEM14* (AGOS_AAR021W), *AgERV2* (AGOS_ACR175W), and *AgERO1* (AGOS_ADL348W)} in genes encoding flavoproteins in *S. cerevisiae*. It is possible that the riboflavin overproduction in the MT strain is associated with these mutations of genes encoding flavoproteins and dysfunction of the TCA cycle. MT strain is hypothesized to have mitochondrial dysfunction because most genes in the TCA cycle and genes encoding flavoproteins have heterozygous mutations. One homozygous mutation in *AgILV2* gene which encodes a flavoprotein, AHAS, localized in mitochondria, was also found (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). In humans, riboflavin supplementation rescues the mitochondrial disorders associated with the deficiencies of some flavoproteins and respiratory chains \[[@CR42]\]. Additionally, we previously reported that the expression of genes involved in TCA cycles in MT strain was decreased compared to WT strain. Also the MT strain shown the decreased succinate and increased lactate and pyruvate compared to WT strain \[[@CR13], [@CR16]\]. These previous results also suggest the overproduction of riboflavin in the MT strain may also be associated with mitochondrial dysfunction. Table 2Heterozygous mutations in genes involved in metabolismsChromosomePositionWt seq.MT seqQualityMutationGeneProductDNA changesProtein changesRead numberMT seq. RatioWT seq.MT seq.Glycolysis/Gluconeogenesis III456,890CT327.19missenseAGOS_ACR056WPhosphoglycerate mutase (AgGPM1)c.374C \> Tp.A125V28120.300 IV287,997TC503.19missenseAGOS_ADL237C6-phosphofructo-2-kinase (AgPFK26)c.1796A \> Gp.D599G24180.429 IV1,362,124AT725.19missenseAGOS_ADR368WPyruvate kinase (AgPYK1)c.1040A \> Tp.K347M21230.523 V242,262AC708.19missenseAGOS_AEL208WAlpha subunit of phosphofructokinase (AgPFK1)c.2255A \> Cp.K752T27230.460 V426,255CT700.19missenseAGOS_AEL106WFructose-2,6-bisphosphatase (AgFBP26)c.103C \> Tp.R35W21230.523 VI96,950AC1088.19missenseAGOS_AFL185WBeta subunit of phosphofructokinase (AgPFK2)c.1963A \> Cp.N655H35370.514 VI97,509ATA907.15frameshiftAGOS_AFL185WBeta subunit of phosphofructokinase (AgPFK2)c.2526Tdelp.Phe842fs20320.615TCA cycle I346,384GA758.19missenseAGOS_AAR004CCitrate synthase (AgCIT1)c.68C \> Tp.T23M18250.581 I634,291GT991.19NonsenseAGOS_AAR162CPyruvate carboxylase (AgPYC2)c.3266c \> Ap.S1089\*31330.514 I634,669AT836.19missenseAGOS_AAR162CPyruvate carboxylase (AgPYC2)c.2888 T \> Ap.L963Q21260.553 III238,489TG729.19missenseAGOS_ACL065CIron-sulfur protein subunit of succinate dehydrogenase (AgSDH2)c.697A \> Cp.T233P25230.479 III238,962GA1051.19missenseAGOS_ACL065CIron-sulfur protein subunit of succinate dehydrogenase (AgSDH2)c.224C \> Tp.T75M20320.615 III451,903GA879.19missenseAGOS_ACR052WFlavoprotein subunit of succinate dehydrogenase (AgSDH1)^a^c.1132G \> Ap.D378N17270.614 IV403,968CT488.19missenseAGOS_ADL164CMalate dehydrogenase (AgMDH2)c.196G \> Ap.A66T27160.372 IV644,214AG568.19missenseAGOS_ADL032WAconitase (AgACO1)c.1367A \> Gp.D456G10160.615 V1,328,889CA922.19missenseAGOS_AER374CSubunit of the mitochondrial alpha-ketoglutarate dehydrogenase (AgKGD1)c.1837G \> Tp.D613Y27270.5 V1,328,948GA711.19missenseAGOS_AER374CSubunit of the mitochondrial alpha-ketoglutarate dehydrogenase (AgKGD1)c.1778C \> Tp.T593M25230.479 VI810,404GT482.19missenseAGOS_AFR207CSubunit of succinate dehydrogenase (AgSDH3)c.200C \> Ap.S67Y20180.473 VI1,103,105GA636.19missenseAGOS_AFR367WFumarate reductase (AgOSM1)c.622G \> Ap.A208T21190.475 VI1,585,840GT635.19missenseAGOS_AFR629WAconitase (AgACO2)c.1894G \> Tp.D632Y36240.400 VII1,652,466AG970.19missenseAGOS_AGR323CE3-binding protein of pyruvate dehydrogenase (AgPDX1) ^a^c.677 T \> Cp.L226P16280.636 VI681,082CT624.19missenseAGOS_AFR134CAlpha subunit of succinyl-CoA ligase (AgLSC1)c.193G \> Ap.A65T23240.510Mitochondria II324,797AG633.19missenseAGOS_ABL038WMitochondrial aspartate aminotransferase (AgAAT1)c.224A \> Gp.D75G20190.487 II325,256CT487.19missenseAGOS_ABL038WMitochondrial aspartate aminotransferase (AgAAT1)c.683C \> Tp.T228M25180.419 IV532,772CA1079.19missenseAGOS_ADL087WCytochrome b reductase (AgCBR1)^a^c.155C \> Ap.T52N25340.576 IV1,458,400GT559.19missenseAGOS_ADR417WMitochondrial aldehyde dehydrogenase (AgALD4)c.561G \> Tp.W187C21170.447 V1,227,029GA503.19missenseAGOS_AER321WMitochondrial D-lactate dehydrogenase (AgDLD1) ^a^c.190G \> Ap.A64T11150.577 VI899,775GA668.19missenseAGOS_AFR255WMitochondrial tRNA translation optimization 1 (MTO1) ^a^c.1423G \> Ap.G475S27220.449 VI1,243,899CT819.19missenseAGOS_AFR447CNADH:ubiquinone oxidoreductase (AgNDI1) ^a^c.943G \> Ap.V315M16260.619 VII1,441,269CA874.19missenseAGOS_AGR196WGlutathione-disulfide reductase (AgGLR1) ^a^c.1415C \> Ap.S472Y27280.509Riboflavin metabolism II194,781GT733.19missenseAGOS_ABL109WRiboflavin kinase (AgFMN1)c.80G \> Tp.S27I20220.524 IV182,017GA687.19missenseAGOS_ADL296CGTP cyclohydrolase II (AgRIB1)c.230C \> Tp.P77L23230.500Glycine, serine, threonine metabolism I448,391GA962.19missenseAGOS_AAR059CThreonine synthase (AgTHR4)c.685C \> Tp.R229W19290.604 III125,457GA821.19missenseAGOS_ACL130CPhosphoserine phosphatase (AgSER2)c.140C \> Tp.A47V28270.491 III727,688CT572.19missenseAGOS_ACR215CSerine hydroxymethyltransferase (AgSHM2)c.593G \> Ap.R198Q24200.455 VII1,057,290TC592.19missenseAGOS_AGR012CCystathionine beta-synthase (AgCYS4)c.269A \> Gp.K90R16190.543 VII1,446,998AG720.19missenseAGOS_AGR200WThreonine aldolase (AgGLY1)c.1088A \> Gp.Y363C14200.588Branched-chain amino acid metabolism I305,862GA960.19missenseAGOS_AAL021WSmall subunit of acetohydroxyacid synthase (AgILV6)c.140G \> Ap.S47N25290.537 I305,877GA923.19missenseAGOS_AAL021WSmall subunit of acetohydroxyacid synthase (AgILV6)c.155G \> Ap.S52N28300.517 I306,395GT711.19missenseAGOS_AAL021WSmall subunit of acetohydroxyacid synthase (AgILV6)c.673G \> Tp.G225C23220.489 II729,493GA1028.19missenseAGOS_ABR174WBranched-chain amino acid biosynthesis activator (AgLEU3)c.704G \> Ap.G235D23330.589 II730,278GA915.19missenseAGOS_ABR174WBranched-chain amino acid biosynthesis activator (AgLEU3)c.1489G \> Ap.A497T22260.542 VI12,855CA543.19missenseAGOS_AFL229W2-isopropylmalate synthase (AgLEU4)c.1051C \> Ap.P351T26190.422 VII1,381,676CT564.19missenseAGOS_AGR169W3-isopropylmalate dehydratase (LEU1)c.226C \> Tp.H76Y12170.586 VII1,382,933TC745.19missenseAGOS_AGR169W3-isopropylmalate dehydratase (LEU1)c.1483 T \> Cp.S495P26250.490Aromatic amino acid metabolism II206,627CT580.19missenseAGOS_ABL102C3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) synthase (AgARO3)c.935G \> Ap.C312Y28180.391 II799,743CA554.19missenseAGOS_ABR209WAnthranilate synthase (AgTRP2)c.982C \> Ap.L328I15160.516 VI1,313,765TA750.19missenseAGOS_AFR485CTryptophan synthase (AgTRP5)c.1917A \> Tp.Q639H33290.468 VI1,426,745GT476.19missenseAGOS_AFR548CAromatic aminotransferase I (AgARO8)c.544C \> Ap.P182T29160.356 VII1,157,861GA690.19missenseAGOS_AGR066WPentafunctional aromatic polypeptide (AgARO1)c.3536G \> Ap.R1179H22210.488 VII1,158,247GA921.19missenseAGOS_AGR066WPentafunctional aromatic polypeptide (AgARO1)c.3922G \> Ap.G1308S29310.517Sulfur amino acid metabolism I361,523GA834.19missenseAGOS_AAR010WTranscriptional activator of sulfur metabolism (AgMET28)c.719G \> Ap.R240Q28250.472 II259,309CT578.19missenseAGOS_ABL077WBeta subunit of sulfite reductase (AgMET5) ^a^c.3002C \> Tp.A1001V25190.432 II804,448CT685.19missenseAGOS_ABR212CCobalamin-independent methionine synthase (AgMET6)c.499G \> Ap.G167S25230.479 III259,886CA1053.19missenseAGOS_ACL059CPeroxisomal cystathionine beta-lyase (AgSTR3)c.1210G \> Tp.V404L16320.667 III585,577CA547.19missenseAGOS_ACR134WFolylpolyglutamate synthetase (AgMET7)c.1135C \> Ap.L379M25170.405 IV646,485GA838.19missenseAGOS_ADL031WO-acetyl homoserine-O-acetyl serine sulfhydrylase (AgMET17)c.302G \> Ap.G101D23260.531 V1,338,633GA974.19missenseAGOS_AER377CComponent of cytosolic iron-sulfur protein assembly machinery (AgMET18)c.1061C \> Tp.T354I28310.525 VI1,699,984CA936.19missenseAGOS_AFR682CL-homoserine-O-acetyltransferase (AgMET2)c.1045G \> Tp.A349S20320.615 VI1,720,007CT393.19missenseAGOS_AFR692CS-adenosylmethionine synthetase (AgSAM2)c.731G \> Ap.G244D30130.302 VII1,511,391CA892.19missenseAGOS_AGR237CAlpha subunit of assimilatory sulfite reductase (AgMET10)c.2268G \> Tp.E756D22280.560 VII1,512,792CA606.19missenseAGOS_AGR237CAlpha subunit of assimilatory sulfite reductase (AgMET10)c.867G \> Tp.E289D27220.449 VII1,685,571GA715.19missenseAGOS_AGR343WComponent of cytosolic iron-sulfur protein assembly (CIA) machineryc.563G \> Ap.R188H24210.467Other amino acid metabolism III169,882CT367.19missenseAGOS_ACL096WProline utilization transactivator (AgPUT3)c.382C \> Tp.R128W26140.350 IV98,235CA727.19missenseAGOS_ADL346WAlpha-aminoadipate reductase (AgLYS2)c.1648C \> Ap.L550M27230.460 VI1,397,559CA864.19missenseAGOS_AFR534WSmall subunit of carbamoyl phosphate synthetase (AgCPA1)c.976C \> Ap.P326T29250.463 VII389,521CA724.19missenseAGOS_AGL165WProline oxidase (AgPUT1) ^a^c.104C \> Ap.T35K28240.462 VII1,708,538TG528.19missenseAGOS_AGR357WAsparaginase (AgASP1)c.311 T \> Gp.I104R19170.472Purine, pyrimidine nulceotide metabolism I558,677GA532.19missenseAGOS_AAR120CPhosphoribosyl-glycinamide transformylase (AgADE8)c.218C \> Tp.T73I16160.500 II269,595CA593.19missenseAGOS_ABL070CXanthine-guanine phosphoribosyl transferase (AgXPT1)c.232G \> Tp.D78Y29220.431 II784,947GA618.19missenseAGOS_ABR204CAMP deaminase (AgAMD1)c.1553C \> Tp.T518I38210.356 III132,857CA773.19missenseAGOS_ACL121CTrifunctional C1-tetrahydrofolate synthase (AgADE3)c.2067G \> Tp.R689S21250.543 III214,069AT441.19missenseAGOS_ACL077CRibose-5-phosphate isomerase (AgRKI1)c.17 T \> Ap.I6N29170.370 III636,192AT711.19missenseAGOS_ACR160CNicotinate phosphoribosyltransferase (AgNPT1)c.84 T \> Ap.N28K26240.480 III654,234CT690.19missenseAGOS_ACR170CUridylate kinase (AgURA6)c.152G \> Ap.R51H14210.600 III715,325GT697.19missenseAGOS_ACR210CPhosphoribosylaminoimidazole carboxylase (AgADE2)C.926C \> Ap.A309D23210.477 III832,220CT957.19missenseAGOS_ACR263CBifunctional carbamoylphosphate synthetase/aspartate transcarbamylase (AgURA2)c.2275G \> Ap.E759K19310.620 III832,428CT745.19missenseAGOS_ACR263CBifunctional carbamoylphosphate synthetase/aspartate transcarbamylase (AgURA2)c.2067G \> Ap.M689I27230.460 IV580,072GT461.19missenseAGOS_ADL057WLarge subunit of ribonucleotide reductase (AgRNR1)c.2520G \> Tp.K840N16150.483 V792,520TC1069.19missenseAGOS_AER083C5-phospho-ribosyl-1-pyrophosphate synthetase (AgPRS1)c.488A \> Gp.Q163R24330.578 VI896,312AT502.19missenseAGOS_AFR254CAminoimidazole ribotide synthetase and glycinamide ribotide synthetase (AgADE5,7)c.1654 T \> Ap.L552I20150.428 VI978,821CA584.19missenseAGOS_AFR297WMyb-related transcription factor (AgBAS1)c.905C \> Ap.P302H23200.465 VII108,330GA674.19missenseAGOS_AGL320CCTP synthase (AgURA7)c.1361C \> Tp.T454I23250.521 VII430,379GA703.19missenseAGOS_AGL146WGTP cyclohydrolase (AgURC1)c.1247G \> Ap.G416D27210.438 VII1,072,826TC377.19missenseAGOS_AGR022CNicotinic acid mononucleotide adenylyltransferase (AgNMA1)c.814A \> Gp.T272A26130.333Fatty acid metabolism I564,702GA769.19missenseAGOS_AAR124CCarnitine acetyl-CoA transferase (AgCAT2)c.1736C \> Tp.S579F19230.548 IV1,430,996GA829.19missenseAGOS_ADR403COleate-activated transcription factor (AgOAF1 or AgPIP2)c.1405C \> Tp.R469C22260.542 IV1,436,329GT757.19missenseAGOS_ADR405COleate-activated transcription factor (AgOAF1 or AgPIP2)c.2170C \> Ap.L724I35280.444 IV1,437,793GA800.19stop_gainedAGOS_ADR405COleate-activated transcription factor (AgOAF1 or AgPIP2)c.706C \> Tp.Q236\*30250.455 IV1,443,883TA729.19nonsenseAGOS_ADR408WAcetyl-coA synthetase (AgACS1)c.1128 T \> Ap.Tyr376\*21230.523 V794,683TC631.19missenseAGOS_AER085CBeta subunit of fatty acid synthetase (AgFAS1) ^a^c.5837A \> Gp.K1946R23190.452 V797,843TG419.19missenseAGOS_AER085CBeta subunit of fatty acid synthetase (AgFAS1) ^a^c.2677A \> Cp.K893Q38150.283 V797,858CA1299.19missenseAGOS_AER085CBeta subunit of fatty acid synthetase (AgFAS1) ^a^c.2662G \> Tp.D888Y14380.731 VI172,719AT746.19missenseAGOS_AFL138WAlpha subunit of fatty acid synthetase (AgFAS2)c.7A \> Tp.M3L19260.578 VI175,856CA656.19missenseAGOS_AFL138WAlpha subunit of fatty acid synthetase (AgFAS2)c.3144C \> Ap.F1048L21210.500 VI1,507,650TA742.19missenseAGOS_AFR592W1-acyl-sn-glycerol-3-phosphate acyltransferase (AgSLC1)c.832A \> Tp.L278M21220.512 VII421,657GT728.19missenseAGOS_AGL148CAcetyl-coA synthetase (AgACS2)c.772C \> Ap.Q258K24240.500 VII422,089CT804.19missenseAGOS_AGL148CAcetyl-coA synthetase (AgACS2)c.340G \> Ap.A114T25260.510 VII913,244CA553.19missenseAGOS_AGL060W3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase (AgFOX2)c.814C \> Ap.P272T25170.405Heme biosynthesis I380,486AC573.19missenseAGOS_AAR021WProtoporphyrinogen oxidase (AgHEM14) ^a^c.617A \> Cp.E206A30210.412 II203,080TC1002.19missenseAGOS_ABL104C5-aminolevulinate synthase (AgHEM1)c.1397A \> Gp.E466G18310.633 V1,281,270TA552.19nonsenseAGOS_AER351WUroporphyrinogen-III synthase (AgHEM4)c.762 T \> Ap.Y254\*19200.513 VII1,608,654AAG453.15frameshiftAGOS_AGR298CS-adenosyl-L-methionine uroporphyrinogen III transmethylase (AgMET1)c.1412dupCp.A472fs19190.500Other flavoprotein III660,436GT853.19missenseAGOS_ACR175WSulfhydryl oxidase (AgERV2) ^a^c.441G \> Tp.W147C28280.500 IV94,090GA485.19missenseAGOS_ADL348WEndoplasmic oxidoreductin1 (AgERO1) ^a^c.386G \> Ap.S129N20180.474Folate metabolism VII1,665,459GA658.19missenseAGOS_AGR330WAminodeoxychorismate lyase (AgABZ2)c.208G \> Ap.V70M29230.442 VII1,674,504CA813.19missenseAGOS_AGR335CGTP-cyclohydrolase I (AgFOL2)c.343G \> Tp.D115Y30250.455These heterozygous mutations are a subset among all 1382 heterozygous mutations which are shown in Table [S2](#MOESM1){ref-type="media"}^a^Flavoproteins\*Translation stops here Table 3Number of mutated genes encoding flavoproteinsTotal^a^HomozygousHeterozygousMutation rateFAD-dependent361 (1)11 (9)33.3%FMN-dependent161 (1)2 (1)18.8%^a^Total number of each flavoproteins is showed based on the reference by Gudipati et al. \[[@CR42]\]Each bracket indicates the number of mutated genes encoding mitochondrial proteins

Related to the heterozygous mutations in flavoprotein genes, a heterozygous mutation in the *AgFMN1* gene (AGOS_ABL109W) was detected (Table [2](#Tab2){ref-type="table"}). In *S. cerevisiae*, this gene encodes riboflavin kinase, which catalyzes the synthesis of FMN from riboflavin. FMN is converted to FAD by FAD synthase. The downregulation of *AgFMN1* gene expression prevented riboflavin consumption in this fungus, and the *ribC*-deleted mutant deregulated riboflavin production in *B. subtilis* by preventing FMN and FAD accumulation \[[@CR43], [@CR44]\]. Therefore, this mutation may partially contribute to riboflavin overproduction in the MT strain by partial restriction of the riboflavin flow to FMN. Additionally, heterozygous mutations were also detected in genes involved in heme biosynthesis and sulfur metabolism (Table [2](#Tab2){ref-type="table"}).

We detected homozygous mutations in the *AgSHM2*, *AgARO2*, *AgILV2*, and *AgLYS5* genes involved in amino acid biosynthesis (Table [1](#Tab1){ref-type="table"}). Heterozygous mutations in genes involved in amino acid metabolism were concentrated in glycine, serine, and threonine metabolism; branched-chain amino acid biosynthesis; and aromatic amino acid biosynthesis (Table [2](#Tab2){ref-type="table"}). In our previous study, the increased expression of AgTRP2 (ABR209W) and AgTRP5 (AFR485C) was observed in MT strain by a proteomic analysis. AgTRP2 and AgTRP5 are annotated as anthranilate synthase and tryptophan synthase, respectively, which belong to the tryptophan biosynthetic pathway. These results suggest that these amino acid metabolic pathways may be linked to riboflavin production in *A. gossypii*.

Several heterozygous mutations were detected in genes involved in sulfur amino acid metabolism. In particular, the sulfur amino acid biosynthesis pathway contains heterozygously mutated genes in the MT strain {*AgMET5* (AGOS_ABL077W), *AgMET6* (AGOS_ABR212C), *AgSTR3* (AGOS_ACL059C), *AgMET17* (AGOS_ADL031W), *AgMET2* (AGOS_AFR682C), *AgSAM2* (AGOS_AFR692C), *AgMET10* (AGOS_AGR237C)}. Mainly, genes encoding all enzymes that catalyze homocysteine in *S. cerevisiae*, except the adenosylhomocysteinase encoded by the *AgSAH1* gene, were heterozygously mutated. These results suggest that methionine metabolism, which consists of one-carbon metabolism together with folate metabolism, may be associated with riboflavin production in *A. gossypii*. The *AgMET10* and *AgMET5* genes encode alpha and beta subunits of sulfite reductase *in S. cerevisiae*, respectively, which are both flavoproteins.

It was previously reported that riboflavin production in *A. gossypii* was improved by disruption of the *AgURA3* gene, which leads to blockage of the pyrimidine biosynthetic pathway in this organism \[[@CR33]\]. In the MT strain, several genes in the pyrimidine biosynthetic pathway have heterozygous mutations (Table [2](#Tab2){ref-type="table"}). These results suggest that pyrimidine metabolism, including the pyrimidine de novo and salvage pathways, may be associated with riboflavin production in *A. gossypii*. In the purine biosynthetic pathway, the *AgRKI1* (AGOS_ACL077C), *AgRPS1* (AGOS_AER083C), *AgADE5,7* (AGOS_AFR254C), *AgADE8* (AGOS_AAR120C), and *AgADE2* (AGOS_ACR210C) genes have heterozygous mutations in the MT strain. Moreover, the AgBAS1 gene (AGOS_AFR297W), which encodes the transcription factor for regulation of the purine and glycine biosynthesis pathways in *A. gossypii* \[[@CR45]\], also has one heterozygous mutation. These heterozygous mutations may partially force the restriction of purine biosynthesis, which is important for riboflavin production in *A. gossypii*. This limited purine biosynthesis in *A. gossypii* was also reported by Ledesma-Amaro et al., who showed the downregulation of purine biosynthesis during riboflavin production \[[@CR43]\].

In addition to mutations in genes involved in metabolic pathways in *A. gossypii*, 17 heterozygous mutations in genes involved in DNA repair were detected (Table [4](#Tab4){ref-type="table"}). In particular, genes involved in mismatch DNA repair {*AgMSH2* (AGOS_AAL093C), *AgMSH3* (AGOS_ADR168C), *AgMSH6* (AGOS_AGR116W), *AgMLH1* (AGOS_AFL199C), *AgMLH2* (AGOS_AFR226C), *AgMLH3* (AGOS_AAL093C), and *AgPMS1* (AGOS_AER421W)} were heterozygously mutated. These proteins function cooperatively to repair DNA mismatches in *S. cerevisiae.* Among MutS homologs, genes encoding AgMSH2, AgMSH3 and AgMSH6 had heterozygous mutations, but no mutation was detected in genes encoding AgMSH1, AgMSH4 and AgMSH5. ScMSH2, ScMSH3 and ScMSH6 of *S. cerevisiae* function to maintain nuclear genome stability \[[@CR46]\]. In contrast, ScMSH1 functions in mitochondria, and ScMSH4 and ScMSH5 function during meiosis \[[@CR47], [@CR48]\]. These results suggest that the heterologous mutations in AgMSH2, AgMSH3 and AgMSH6 may compromise the DNA mismatch repair pathway and contribute to the maintenance of DNA mismatches and accumulation of heterologous mutations in the genome of *A. gossypii* during disparity mutagenesis and rapid evolution of *A. gossypii* to the riboflavin-overproducing mutant MT strain. Previous papers have shown that heterologous mutations of the ScMSH2 gene showed mutator phenotypes in diploid yeasts and suppression of the mismatch repair pathway and proofreading-deficient DNA polymerase ε in human cells, leading to the accumulation of numerous mutations \[[@CR49], [@CR50]\]. However, the riboflavin production level in MT was stable during 14 passages \[[@CR13]\]. Table 4Heterozygous mutations in genes involved in DNA repairChromosomePositionWT seq.MT seqQualityMutationGeneProductDNA changesProtein changesRead numberMT seq ratioWT seq.MT seq.I177,825GT533.19missenseAGOS_AAL093CDNA mismatch repair protein (AgMLH3)c.1516C \> Ap.L506M22170.436IV997,942TG729.19missenseAGOS_ADR168CDNA mismatch repair protein (AgMSH3)c.2937A \> Cp.K979N39230.371IV998,607GA982.19nonsenseAGOS_ADR168CDNA mismatch repair protein (AgMSH3)c.2272C \> Tp.Q758\*22290.569IV1,446,658GT747.19missenseAGOS_ADR411WCheckpoint protein (AgRAD17)c.358G \> Tp.D120Y32240.429V486,710GA711.19missenseAGOS_AEL075WDNA polymerase delta subunit 3 (AgPOL32)c.490G \> Ap.A164T18220.550V1,239,357CA411.19missenseAGOS_AER327CUracil-DNA glycosylase (AgUNG1)c.757G \> Tp.A253S27160.372V1,445,972GA869.19missenseAGOS_AER421WDNA mismatch repair protein (AgPMS1)c.1762G \> Ap.A588T23280.549VI65,368CT587.19missenseAGOS_AFL199CDNA mismatch repair protein (AgMLH1)c.320G \> Ap.C107Y20200.500VI677,447GA967.19nonsenseAGOS_AFR133Csingle-stranded DNA endonuclease (AgRAD2)c.2143C \> Tp.Q715\*25300.545VI677,525CA743.19missenseAGOS_AFR133Csingle-stranded DNA endonuclease (AgRAD2)c.2065G \> Tp.D689Y27280.509VI834,113AG889.19missenseAGOS_AFR220WDNA helicase/Ubiquitin ligase (AgRAD5)c.2419A \> Gp.S807G18250.581VI834,860GT678.19nonsenseAGOS_AFR220WDNA helicase/Ubiquitin ligase (AgRAD5)c.3166G \> Tp.E1056\*29220.431VI848,262AG828.19missenseAGOS_AFR226CDNA mismatch repair protein (AgMLH2)c.1882 T \> Cp.F628L26310.544VI1,528,970CT1142.19nonsenseAGOS_AFR603CDNA mismatch repair protein (AgMSH2)c.2711G \> Ap.W904\*18360.667VI1,529,553GA1151.19missenseAGOS_AFR603CDNA mismatch repair protein (AgMSH2)c.2128C \> Tp.P710S12330.733VII1,278,725TG786.19missenseAGOS_AGR116WDNA mismatch repair protein (AgMSH6)c.1005 T \> Gp.N335K24250.510VII1,368,167CT788.19missenseAGOS_AGR162CDNA repair protein (AgRAD4)c.1214G \> Ap.R405Q17230.575\*Translation stops here

As mentioned above, MT strain never produced its haploid spores. Some heterozygous mutations were found in genes involved in the sporulation (Table [5](#Tab5){ref-type="table"}). Two putative 1,3-β-D-glucan synthase genes (AGOS_ACL181C, AGOS_AAR053W) had heterozygous mutations. Especially, AGOS_AAR053W had one frameshift mutation which may have great influences on the protein function. In *S. cerevisiae*, FKS2 is a 1,3-β-D-glucan synthase during its sporulation and FKS2 and FKS3 works in spore wall assembly \[[@CR51]\]. In addition, FKS2 binds to a sporulation-specific kinase, SMK1 \[[@CR52]\]. Heterozygous mutations of AGOS_ACL181C and AGOS_AAR053W may have some influences on the sporulation in MT strain. Moreover, we found heterozygous mutations in *AgIME2* (AGOS_AFR076W) and *AgKAR4* (AGOS_AFR736C) genes. Disruption of *AgIME2* gene or *AgKAR4* gene leads to the deficiency of its sporulation in *A. gossypii* \[[@CR53]\]. These heterozygous mutations may also be one of the reasons for the sporulation deficiency in MT strain. Table 5Heterozygous mutations in genes involved in sporulationChromosomePositionWT seq.MT seqQualityMutationGeneProductDNA changesProtein changesRead numberMT seq ratioWT seq.MT seq.III41,510TG1253.19missenseAGOS_ACL181C1,3-beta-D-glucan synthase (AgFKS1 or AgGSC2)c.4596A \> Cp.Lys1532Asn23370.617II101,053TG878.19missenseAGOS_ABL159WComponent of the septin ring (AgSHS1)c.1229 T \> Gp.Ile410Ser20290.592IV649,360GA886.19missenseAGOS_ADL029WComponent of the meiotic outer plaque of the spindle pole body (AgSPO74)c.374G \> Ap.Ser125Asn19260.578V965,295AACAG1023.15disruptive_inframe_insertionAGOS_AER177WTranscription factor targeting filamentation genes (AgTEC1)c.1518_1520dupGCAp.Gln507dup21280.571IV1,263,702GT982.19missenseAGOS_ADR317CDual-specificity kinase (AgMPS1)c.2228C \> Ap.Thr743Asn24310.564VI1,158,992AG1022.19missenseAGOS_AFR400CN-formyltyrosine oxidase (AgDIT2)c.635 T \> Cp.Ile212Thr25320.561III48,243CA765.19missenseAGOS_ACL179CMeiosis-specific protein (AgSPO77)c.1601G \> Tp.Arg534Ile18230.561VI1,225,184AC753.19missenseAGOS_AFR436CComponent of the septin ring (AgCDC11)c.371 T \> Gp.Val124Gly21250.543I436,519AAT935.15frameshiftAGOS_AAR053W1,3-beta-D-glucan synthase (AgGSC2 or AgFKS1 or AgFKS3)c.916_917insTp.Arg306fs24280.538VI1,531,918TC659.19missenseAGOS_AFR604CComponent of the meiotic outer plaque of the spindle pole body (AgSPO21)c.2531A \> Gp.Gln844Arg18200.526VI1,288,694GT943.19missenseAGOS_AFR469Wt-SNARE protein (AgSEC9)c.918G \> Tp.Glu306Asp27290.518VI672,483CT645.19missenseAGOS_AFR130WProtein involved in the control of meiotic nuclear division (AgSSP1)c.121C \> Tp.Leu41Phe20210.512IV1,456,401GT500.19missenseAGOS_ADR416WMitotic exit network scaffold protein (AgNUD1)c.1263G \> Tp.Gln421His16160.500VI639,702CT610.19missenseAGOS_AFR111CComponent of the septin ring (AgCDC3)c.203G \> Ap.Gly68Asp22220.500VII1,087,176GA676.19missenseAGOS_AGR031WTranscriptional repressor (AgNRG1 or AgNRG2)c.107G \> Ap.Ser36Asn25240.490VI1,225,449AT596.19missenseAGOS_AFR436CComponent of the septin ring (AgCDC11)c.106 T \> Ap.Ser36Thr25210.457V1,436,486GA466.19missenseAGOS_AER416CEH domain-containing protein (AgEND3)c.4C \> Tp.Pro2Ser21170.447VI566,815AC758.19missenseAGOS_AFR076WSerine/threonine protein kinase (AgIME2)c.1142A \> Cp.Tyr381Ser30240.444IV1,423,888GA643.19missenseAGOS_ADR400WGamma-tubulin small complex receptor (AgSPC72)c.278G \> Ap.Ser93Asn24190.442IV650,376AT523.19missenseAGOS_ADL029WComponent of the meiotic outer plaque of the spindle pole body (AgSPO74)c.1390A \> Tp.Ile464Phe26190.422VII394,750GA560.19missenseAGOS_AGL162CSm-like protein (AgSEC1)c.1972C \> Tp.Pro658Ser26190.422III506,687TG578.19missenseAGOS_ACR083CMeiosis-specific component of the spindle pole body (AgDON1 or AgCUE5)c.237A \> Cp.Arg79Ser28180.391III38,740CA576.19missenseAGOS_ACL182C1,3-beta-glucanosyltransferase (AgGAS2)c.1161G \> Tp.Glu387Asp40210.344VI1,794,575AC577.19missenseAGOS_AFR736CTranscription factor required for response to pheromones (AgKAR4)c.422 T \> Gp.Phe141Cys46210.313

Gene Ontology (GO) enrichment analysis was performed (Supplementary materials Tables [S3](#MOESM1){ref-type="media"}, [S4](#MOESM1){ref-type="media"} and [S5](#MOESM1){ref-type="media"}) in the set of genes containing homozygous or heterozygous mutations. Over-represented GO terms are ATP binding, Protein binding and ATPase activity. Especially, in "ATP binding", all 22 ATP-dependent helicase genes have a single heterologous mutation, respectively. It was recently reported that RNA helicases have the relationship with aging and life span of cells \[[@CR54]\]. Mutations of all RNA helicase genes support the suggestion that riboflavin production in *A. gossypii* may be associated with the aging of cells. Interestingly, we also found 25 mutated genes among 139 genes in "oxidation-reduction process" (Supplementary materials Table S3) and no mutated gene was in "mitochondrion". This result suggests that oxidative stress is more associated with the riboflavin over-production in MT strain than the mitochondrial dysfunction and supports the previous study showing a riboflavin-overproducing *A. gossypii* mutant is vulnerable to photoinduced oxidative DNA damage and accumulate ROS \[[@CR23]\], leading to the aging of cells. On the other hand, "Ribosome", "Translation", "Structural constituent of ribosome" and "Intracellular" were under-represented. These GO terms contain ribosomal proteins involved in translation (Supplementary materials Tables [S5](#MOESM1){ref-type="media"}). Mutations of genes encoding these proteins are lethal in organisms and, therefore, these GO terms were under-presented.

Effect of temperature on riboflavin production in MT strain {#Sec4}
-----------------------------------------------------------

By genomic analysis of the MT strain, one homozygous mutation in the *AgHSP104* gene (AGOS_AGL036C), which causes a nonsense mutation, was detected (Table [1](#Tab1){ref-type="table"}). This mutation generates the mutated AgHSP104, composed of 355 amino acid residues at its N-terminus. HSP104 in fungi contributes to the thermotolerance and disaggregation of denatured and aggregated proteins, ethanol tolerance and survival in the stationary phase \[[@CR55]\]. We confirmed this nonsense mutation in the MT strain by DNA sequencing (Fig. [3](#Fig3){ref-type="fig"}a). In addition, other four homozygous mutations in the MT strain were also confirmed by DNA sequencing (Data not shown). These results validate the results of the genomic analysis. The WT and MT strains were cultivated on YD medium at 28 and 37 °C. The growth and riboflavin production in WT cultivated at 37 °C were slightly lower than those in WT cultivated at 28 °C (Fig. [3](#Fig3){ref-type="fig"}b). However, the growth of and riboflavin production in the MT strain were dramatically reduced at 37 °C compared to those at 30 °C, and the MT strain was not able to grow normally. These results reflected the generation of truncated AgHSP104 in the MT strain, leading to loss of thermotolerance, even at 37 °C. This result also confirms the presence of the homozygous mutation in the *AgHSP104* gene of the MT strain. Which corresponds, a homozygous missense mutation was found in *AgPMT1* gene (AGOS_ADR279C) (Supplementary materials Table [S1](#MOESM1){ref-type="media"}). This encodes a putative *O*-mannosyltransferase which is essential for the cell wall integrity by *O*-glycosylation of cell wall mannoproteins. In *Aspergillus*, the disruption of the genes caused the high sensitivity of growth temperature and low cell wall integrity \[[@CR56], [@CR57]\]. This mutation may also partially contribute to the high sensitivity of growth temperature in MT strain. Fig. 3Growth and riboflavin production of MT strain. **a** Sequence of *AgHSP104* gene in the MT strain. The gene sequence was confirmed by Sanger method. **b** Growth of and riboflavin production in WT and MT on YD medium at 28 and 37 °C for 5 d

Effect of iron for the riboflavin production in MT strain {#Sec5}
---------------------------------------------------------

In Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}, many heterozygous mutations were detected in genes encoding proteins involved in mitochondrial function and DNA. Iron-sulfur (Fe/S) clusters are required for TCA cycles, the electron transfer chain and fatty acid oxidation in mitochondria and DNA repair in nucleus \[[@CR58], [@CR59]\]. Therefore, the addition of iron ion for the MT strain cultivation was investigated. Fe^3+^ enhanced the growth of mycelia and riboflavin production in the MT strain (Fig. [4](#Fig4){ref-type="fig"}a) also in the presence of glycine, which is well-known for the improvement of the riboflavin production in *A. gossypii*. Addition of Fe^3+^ and Fe^3+^ + glycine improved the riboflavin production of MT strain by 1.6 and 2.0 fold, respectively although we were not able to find its significant differences. (Fig. [4](#Fig4){ref-type="fig"}b). Specific riboflavin production of MT strain in the presence of Fe^3+^ and Fe^3+^ + glycine were also improved by 1.4 and 1.3 fold, respectively although we were not able to find its significant differences. These results indicate that Fe^3+^ and glycine enhanced the riboflavin production by the improvement of its growth. Flavoproteins in mitochondria of yeasts function in redox processes via the transfer of electrons \[[@CR41]\]. In addition, the flavin in flavoproteins participates in iron metabolism. We found two homozygous mutations (*AgARO2*, *AgILV2*) and 13 heterozygous mutations (*AgSDH1*, *AgPDX1*, *AgNDI1*, *AgDLD1*, *AgCBR1*, *AgGLR1*, *AgMTO1*, *AgMET5*, *AgPUT1*, *AgFAS1*, *AgHEM14*, *AgERV2*, and *AgERO1*) in genes encoding putative flavoproteins. Most of these flavoproteins may localized in mitochondria (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). We previously reported that lactate and pyruvate was produced more in MT strain than WT strain in the minimum medium and succinate was decreased in MT strain compared to WT stain \[[@CR16]\]. In addition, gene expression of most of genes involved in TCA cycle was down-regulated in MT strain cultivated compared to WT stain \[[@CR13]\]. In Fig. [4](#Fig4){ref-type="fig"}, the growth and riboflavin production in MT strain were enhanced by the addition of iron ion, which is involved in mitochondrial functions with flavoproteins \[[@CR41], [@CR58], [@CR59]\]. This result also supports the relationship of riboflavin production with the mitochondrial dysfunction. The addition of Fe^2+^ had no effect on the riboflavin production in WT strain (Data not shown). Fig. 4Growth and riboflavin production in the WT and MT strains in the presence of Fe^3+^ and glycine. **a** Growth of WT and MT strains on the minimum medium plate containing Fe^3+^ and glycine. Fe^3+^ and glycine were supplemented at 27 mg/L and 1 mM, respectively. **b** Riboflavin production of MT strain n minimal medium supplemented with 27 mg/L Fe^3+^ and 1 mM glycine. The amount of riboflavin and dry cell was measured at 4 days. Metal ions except for Fe^3+^ were not supplemented in both cultivations

Conclusion {#Sec6}
==========

In this study, we analyzed the genomic sequence of the riboflavin-overproducing mutant MT strain and detected some intriguing homozygous and heterozygous mutations in the coding sequences of the MT genome. The homozygous and heterozygous mutations were concentrated in genes encoding proteins involved in the TCA cycle, mitochondrial functions, sulfur metabolism and DNA mismatch repair. The discovery of many heterozygous mutations indicates that mutants with many heterozygous mutations cannot be isolated by conventional mutagenesis methods, such as the use of mutagens and genetic engineering. Disparity mutagenesis is a promising tool for the creation of new types of eukaryotic mutants in various research fields and manufacturing industries. Additionally, the genomic analysis and GO enrichment analysis showed the relationship of the riboflavin production in MT strain with oxidative stress and the aging of cells, supporting the previous result that the accumulation of ROS and DNA damages appeared in other *A.gossypii* riboflavin-overproducing mutant \[[@CR23]\].

Methods {#Sec7}
=======

Strains and cultivation {#Sec8}
-----------------------

*A. gossypii* ATCC10895, which was purchased from American Type Culture Collection (ATCC), was used as a wild-type strain (WT strain). The *A. gossypii* w122032 mutant (MT strain) was previously isolated by disparity mutagenesis in the presence of H~2~O~2~, itaconate and oxalate \[[@CR13]\] and used as a mutant strain in this study. These strains were maintained at 28 °C in YD medium (1% yeast extract, 1% glucose, pH 6.8). Chemically defined medium (15 g/L glucose as a carbon source, 1.5 g/L asparagine, 0.75 g/L KH~2~PO~4~, 0.1 g/L myo-inositol, pH 6.8) was used as a minimal medium \[[@CR16]\]. To cultivate *A. gossypii* in flasks, mineral ions (4.4 mg/L CoCl~2~·6H~2~O, 18.0 mg/L MnCl~2~·4H~2~O, 44.0 mg/L ZnSO~4~·7H~2~O, 10.1 mg/L MgSO~4~·7H~2~O, 27.0 mg/L FeCl~3~·6H~2~O, 21.9 mg/L CaCl~2~·6H~2~O, and 2.7 mg/L CuSO~4~·5H~2~O) were added to the minimal medium. Cultivation was carried out using a 500-ml flask (working volume 50 ml) with an agitation rate of 120 rpm at 28 °C. The chemically defined medium was used for cultivation on agar plates. Each amino acid was used to supplement the media at 1 mM.

Assay {#Sec9}
-----

The amount of riboflavin was determined according to a previous protocol \[[@CR16]\]. Briefly, 0.8 mL of the culture broth was thoroughly mixed with 0.2 mL of 1 N NaOH. A 0.4-mL aliquot of the resulting solution was neutralized with 1 mL of 0.1 M potassium phosphate buffer (pH 6.0), and the absorbance of the solution at a wavelength of 444 nm was measured. The riboflavin concentration was calculated with an extinction coefficient of 1.04 × 10^− 2^ M^− 1^ cm^− 1^ (127 mg riboflavin/L at ABS444).

Genome analysis {#Sec10}
---------------

Genomic DNA was extracted from mycelia cultivated in YD medium during the logarithmic phase using the DNeasy Plant Mini Kit (Qiagen, Venlo, Netherlands) and fragmented using a Covaris Acoustic Solubilizer (Covaris, Woburn, MA, USA). Genomic libraries were prepared using the TruSeq Nano DNA Library Prep Kit (Illumina, San Diego, CA, USA) and sequenced using a MiSeq system (Illumina) at the Instrumental Research Support Office, Research Institute of Green Science and Technology, Shizuoka University.

Paired-end reads (2 × 301 bp) were cleaned up using Trimmomatic ver. 0.36 \[[@CR60]\] by trimming adapter sequences, low-quality reads (quality score, \< 15), and the final 301 bases, followed by filtering reads less than 150 bp. High-quality reads were aligned to the reference genome of *A. gossypii* ATCC10895 using BWA-MEM ver. 0.7.12 \[[@CR61]\]. Aligned reads were sorted and duplicates were marked using Picard Tools ver. 2.8.0 (<http://broadinstitute.github.io/picard/>). The Genome Analysis Toolkit ver. 3.7 \[[@CR62]\] was used to call variants, SNPs and short insertions/deletions (indels). The variants identified by HaplotypeCaller in GATK were filtered using Variant Filtration under the following settings: QualByDepth (QD) \< 6.0; RMSMappingQuality (MQ) \< 50; Quality (QUAL) \< 100. Annotation of each variant and its functional effect was predicted using SnpEff ver. 4.3 T \[[@CR63]\] with the default database of "*Ashbya_gossypii*". All proteins of *A. gossypii* were annotated using HMMER 3.1b2 (<http://hmmer.org>) against Pfam database 32.0 \[[@CR64]\]. GO terms associated with Pfam entries were assigned using the pfam2go mapping file (<http://www.geneontology.org/external2go/pfam2go>, version date of 2019/06/01). Two-sided Fisher's exact test was performed to find the GO terms over- and under-represented in the homozygously and heterozygously mutated genes. The significance threshold of over- and under-represented GO terms was defined as a false discovery rate (FDR) of 0.05.
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**Additional file 1: Table S1.** All 33 homozygous mutations detected in the coding sequences of the MT genome. **Table S2.** All 1377 heterozygous mutations detected in coding sequences of the MT genome. **Table S3.** Gene Ontology (GO) enrichment analysis of the genes containing mutations. **Table S4.** Genes assigned over-represented Gene Ontology. **Table S5.** Genes assigned under-represented Gene Ontology.

AHAS

:   Acetohydroxyacid synthase

Chr

:   Chromosome

FAD

:   Flavin adenine dinucleotide

FDR

:   False discovery rate

FMN

:   Favin mononucleotide

GO

:   Gene ontology

ICL

:   Isocitrate lyase

indels

:   insertions/deletions

MQ

:   RMSMappingQuality

ORF

:   Open reading frame

PPTase

:   4′-Phosphopantetheinyl transferase

PRPP

:   Phosphoribosyl pyrophosphate

QD

:   QualByDepth

QUAL

:   Quality

ROS

:   Reactive oxygen species

SHMT

:   Serine hydroxymethyltransferase

SNP

:   Single-nucleotide polymorphisms

SNV

:   Single-nucleotide variant
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